Similar to the previously mentioned miRNAs, miR-320a modulates BCR::ABL1 and is downregulated in CML mesenchymal stromal cells (MSCs). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.